Reports
Sale
Global Clinical Trial Biorepository and Archiving Solutions Market: By Products: Preclinical Products, Clinical Products; By Phase: Phase I, Phase II, Phase III, Phase IV; By Services: Biorepository Services, Archiving Services, Others; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Global Clinical Trial Biorepository and Archiving Solutions Market Outlook
The global clinical trial biorepository and archiving solutions market size was valued at USD 4.26 billion in 2023, driven by the increasing prevalence of sports injuries and orthopaedic disorders. The market size is anticipated to grow at a CAGR of 9.0% during the forecast period of 2024-2032 to achieve a value of USD 9.25 billion by 2032.
Clinical Trial Biorepository and Archiving Solutions: Introduction
Clinical trial biorepository and archiving solutions are important when it comes to security and management of biological samples and data related to clinical trials. These are the effective and reliable solutions that are selected by the healthcare professionals to ensure the effective management of the samples and data.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Clinical trial biorepository solutions are the high-quality biological equipment that are required in translational research. These solutions are used in a variety of research applications such as genomics and proteomics, discovery of novel biomarkers, prognostic targets. The requirement in oncology research frequently requires enormous datasets in order to identify the biomarkers, identify treatment response, and in development of new therapies.
Key Trends in the Clinical Trial Biorepository and Archiving Solutions Market
The global market for clinical trial biorepository and archiving solutions is recording significant growth due to factors such as rising clinical trials and the growing complexity of biomedical research, leading to a surge in the volume of biological samples production. These biorepositories provide the necessary infrastructure and expertise to store and manage these samples, making sure their long-term conservation for future purposes.
There are several key trends running in the clinical trial biorepository and archiving solutions market and some of them are adoption of automation and robotics to handle samples, storage processes, and much more. Additionally, increased use of cloud storage and implementation of blockchain technology providing better scalability, cost effectiveness, and enhanced data security, along with several other benefits for the users.
Clinical Trial Biorepository and Archiving Solutions Market Segmentations
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Products
- Preclinical Products
- Clinical Products
Market Breakup by Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Market Breakup by Services
- Biorepository Services
- Archiving Services
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Clinical Trial Biorepository and Archiving Solutions Market Scenario
Biomedical research and drug development are major purposes that are supported by the market of clinical trial biorepository and archiving solutions. Samples that are collected during the clinical trials and testing are stored in the biorepositories in order to ensure the security and suitable environment for the samples. These samples could include tissue, blood, and some other biomaterials, so that researchers could perform and research and study about the disease, generate suitable therapies and improve personalized medicine.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The demand for clinical trial biorepository and archiving solutions is driven by several factors such as increasing difficulties in clinical trials and growing demand for accurate biomarker analysis calls for effective sample handling and storage technologies.
The market for clinical trial biorepository and archiving solutions is expected to grow as the demand for high-quality samples, data integrity, and regulatory compliance continues to grow as well.
Clinical Trial Biorepository and Archiving Solutions Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Azenta U.S., Inc.
- Thermo Fisher Scientific Inc. (Patheon)
- Precision for Medicine, Inc.
- Medpace
- ATCC
- Q2 Solutions
- Labconnect
- Charles River Laboratories
- Cell&Co
- LabCorp Drug Development
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Products |
|
| Breakup by Phase |
|
| Breakup by Services |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Clinical Trial Biorepository and Archiving Solutions Market Overview
3.1 Global Clinical Trial Biorepository and Archiving Solutions Market Historical Value (2017-2023)
3.2 Global Clinical Trial Biorepository and Archiving Solutions Market Forecast Value (2024-2032)
4 Global Clinical Trial Biorepository and Archiving Solutions Market Landscape
4.1 Image Guided Surgery: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Image Guided Surgery: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
5 Global Clinical Trial Biorepository and Archiving Solutions Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Clinical Trial Biorepository and Archiving Solutions Market Segmentation
6.1 Global Clinical Trial Biorepository and Archiving Solutions Market by Products
6.1.1 Market Overview
6.1.2 Preclinical Products
6.1.3 Clinical Products
6.2 Global Clinical Trial Biorepository and Archiving Solutions Market by Phase
6.2.1 Market Overview
6.2.2 Phase I
6.2.3 Phase II
6.2.4 Phase III
6.2.5 Phase IV
6.3 Global Clinical Trial Biorepository and Archiving Solutions Market by Services
6.3.1 Market Overview
6.3.2 Biorepository Services
6.3.3 Archiving Services
6.3.4 Others
6.4 Global Clinical Trial Biorepository and Archiving Solutions Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Clinical Trial Biorepository and Archiving Solutions Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Clinical Trial Biorepository and Archiving Solutions Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Clinical Trial Biorepository and Archiving Solutions Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Clinical Trial Biorepository and Archiving Solutions Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Clinical Trial Biorepository and Archiving Solutions Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Azenta U.S., Inc.
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Thermo Fisher Scientific Inc. (Patheon)
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Precision for Medicine, Inc.
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Medpace
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 ATCC
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Q2 Solutions
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Labconnect
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Charles River Laboratories
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Cell&Co
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 LabCorp Drug Development
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The global market attained a value of about USD 4.26 billion in 2023.
The market is anticipated to grow at a CAGR of 9% during the forecast period of 2024-2032 to attain a value of USD 9.25 billion by 2032.
The key trends in the market include the rising clinical trials and the growing complexity of biomedical research.
The products in the market can be categorised into preclinical products and clinical products.
The phases in the market can be categorised into phase I, phase II, phase III, and phase IV.
The services in the market can be categorised into biorepository and archiving services, among others.
What are the major global regional markets for clinical trial biorepository and archiving solutions?
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The key players involved in the market are Azenta U.S., Inc., Thermo Fisher Scientific Inc. (Patheon), Precision for Medicine, Inc., Medpace, ATCC, Q2 Solutions., Labconnect, Charles River Laboratories, Cell&Co, and LabCorp Drug Development.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER